Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

NCT05874635 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

20000

Enrollment

INDUSTRY

Sponsor class

Conditions

Weight Loss
Metabolic Syndrome
Diabetes Mellitus, Type 2
Central Obesity
Insulin Resistance
Glucose Intolerance
Metabolic Glucose Disorders

Interventions

DEVICE: Continuous Glucose Monitor Device

Sponsor

Signos Inc